Login / Signup

Real-word experience with mepolizumab: Does it deliver what it has promised?

Florence SchleichSophie GraffHaleh NekoeeCatherine MoermansMonique HenketCarole SanchezVirginie PaulusFrançoise GuissardAnne-Françoise DonneauRenaud Louis
Published in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2020)
Mepolizumab is efficient in severe eosinophilic asthma in real life.
Keyphrases
  • chronic obstructive pulmonary disease
  • lung function
  • early onset
  • allergic rhinitis
  • cystic fibrosis
  • drug induced